logo BDSP

Base documentaire

  1. HIV prevention among injecting drug users : Responses in developing and transitional countries.

    Article - En anglais


    Human immunodeficiency virus (HIV) infection associated with injecting drug use has been reported in at least 98 countries and territories worldwide.

    There is evidence that new epidemics are emerging in different regions, including Eastern Europe, Latin America, and the eastern Mediterranean.

    The authors provide a global overview of the situation of HIV infection associated with injecting drug use and responses that have been implemented in various developing and transitional countries.


    Although there has been extensive documentation of the extent and nature of HIV infection associated with injecting drug use in many developed countries and the various interventions implemented in those countries, there is very limited information on the situation in developing and transitional countries.

    This chapter brings together information from a broad range of sources, including published literature ; « grey » or « fugitive » literature ; data collected by the World Health Organization (WHO), the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations International Drug Control Programme (UNDCP) ; personal communications ; and direct observation by the authors.

    The authors have traveled extensively to a wide range of developing and transitional countries and have accessed information not readily available to the international research community.



    Mots-clés Pascal : SIDA, Virose, Infection, Toxicomanie, Voie intraveineuse, Programme sanitaire, Stratégie, Prévention, Evolution, Prévalence, Facteur risque, Evaluation, Homme, Revue bibliographique, Etude multicentrique, Immunopathologie, Immunodéficit

    Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Drug addiction, Intravenous administration, Sanitary program, Strategy, Prevention, Evolution, Prevalence, Risk factor, Evaluation, Human, Bibliographic review, Multicenter study, Immunopathology, Immune deficiency

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0414238

    Code Inist : 002B05C02D. Création : 22/03/2000.